Caffeine downregulates antibody production in a mouse model
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60162694%3AG44__%2F15%3A43875350" target="_blank" >RIV/60162694:G44__/15:43875350 - isvavai.cz</a>
Result on the web
<a href="http://www.sciencedirect.com/science/article/pii/S1214021X14000799" target="_blank" >http://www.sciencedirect.com/science/article/pii/S1214021X14000799</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.jab.2014.09.001" target="_blank" >10.1016/j.jab.2014.09.001</a>
Alternative languages
Result language
angličtina
Original language name
Caffeine downregulates antibody production in a mouse model
Original language description
Caffeine is a secondary plant metabolite found in coffee and tea. Its major pathway is interaction with adenosine receptors. Minor pathways are also known. An effect of caffeine on immunity has been proposed. In this paper, the role of caffeine on the immune system was studied, using a BALB/c mouse model. The animals received saline (controls), keyhole limpet hemocyanin (KLH) 1 mg/kg or caffeine (alone or in combination with KLH) in doses of 1-16 mg/kg. The mice were sacrificed 1-7 days later and plasmalevels of interleukin (IL) 2, 4, 6, 10, 12 and antibodies against KLH were determined by enzyme linked immunosorbent assay (ELISA). Caffeine caused a significant decrease in KLH-stimulated antibody production. The effect was dose dependent. There were similar findings for IL-2 and IL-4 but not for IL-6, IL-10 and IL-12. The significance of the findings is discussed with extrapolation to humans based on caffeine doses used in the study and the amount of caffeine in available beverages.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FR - Pharmacology and apothecary chemistry
OECD FORD branch
—
Result continuities
Project
<a href="/en/project/LH11023" target="_blank" >LH11023: Improvement of vaccination efficacy by cholinergic anti-inflammatory pathway</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2015
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Journal of Applied Biomedicine
ISSN
1214-021X
e-ISSN
—
Volume of the periodical
13
Issue of the periodical within the volume
1
Country of publishing house
CZ - CZECH REPUBLIC
Number of pages
6
Pages from-to
1-6
UT code for WoS article
000350670600001
EID of the result in the Scopus database
—